Doheny Eye Institute appoints SriniVas Sadda, MD, as the A. Ray Irvine, Jr., MD, Endowed Chair

News
Article

Sadda is the second person to serve as chair. The first chairholder was John Irvine, MD, who was appointed to the role in 2001.

(Image Credit: Doheny Eye Institute)

(Image Credit: Doheny Eye Institute)

Doheny Eye Institute announced SriniVas Sadda, MD, director of Artificial Intelligence and Imaging Research at Doheny Eye Institute and professor of Ophthalmology at the University of California – Los Angeles (UCLA) David Geffen School of Medicine, has been named the A. Ray Irvine, Jr., MD, Endowed Chair.

According to a news release, Sadda is the second person to serve as chair. The first chairholder was John Irvine, MD, who was appointed to the role in 2001.1

Deborah A. Ferrington, PhD, chief scientific officer at Doheny Eye Institute, lauded Sadda’s impact on ophthalmology.

“Dr. Sadda has made a remarkable impact on the field of ophthalmology and in vision research, and has a stellar reputation around the globe for his leadership and expertise,” Ferrington said in a statement. “As endowed chair, we look forward to Dr. Sadda continuing his important work that embodies the mission of Dr. A. Ray Irvine, Jr., and Doheny Eye Institute – which is to further the conservation, improvement and restoration of human eyesight.”

During his career, Sadda’s accomplishments include serving as president and chief scientific officer of Doheny Eye Institute, holding the Stephen J. Ryan-Arnold and Mabel Beckman Foundation Endowed Presidential Chair.

Sadda’s research in the use of artificial intelligence in imaging at Doheny, have led to a number of breakthroughs in the understanding of ocular diseases.

Sadda was recently named president of the Association for Research in Vision and Ophthalmology (ARVO) for the 2024-2025 term. He also was named president of the Macula Society, and has been honored with numerous awards from organizations, such as the American Academy of Ophthalmology (AAO), Macula Society, Retina Society, ARVO, among others.

Sadda received his MD from Johns Hopkins University, where he also completed ophthalmology residency and fellowships in neuro-ophthalmology and medical retina (Wilmer Eye Institute).

In a statement, Sadda noted that being named as endowed chair is a tremendous honor and will support his research for many years to come.

“While the scientific community has made tremendous strides in vision research that have led to breakthrough treatments for millions of people who suffer from eye diseases, there is still much more to be done,” Sadda said in a statement. “New technologies, artificial intelligence, and continued collaboration among scientists globally continues to push forward knowledge, and I am eager to continue my part in the crucial effort to help save people’s sight.”

Endowed chairs are an honor bestowed upon faculty who demonstrate excellence in their work and are a product of gifts from donors who support the mission of an institution.

The A. Ray Irvine, Jr., MD, Endowed Chair was established in honor of its namesake who, along with his father A. Ray Irvine, Sr., MD, was among the ophthalmologists who supported Carrie Estelle Doheny in establishing the Estelle Doheny Eye Foundation, which provided the initial funding to create Doheny Eye Institute.1

Reference:
  1. Doheny Eye Institute. Doheny Eye Institute Appoints SriniVas Sadda, MD, as the A. Ray Irvine, Jr., MD, Endowed Chair. GlobeNewswire News Room. Published August 14, 2024. Accessed August 15, 2024. https://www.globenewswire.com/news-release/2024/08/14/2930108/0/en/Doheny-Eye-Institute-Appoints-SriniVas-Sadda-MD-as-the-A-Ray-Irvine-Jr-MD-Endowed-Chair.html
Recent Videos
1 KOL featured in this series.
1 KOL featured in this series.
1 KOL featured in this series.
1 KOL featured in this series.
© 2024 MJH Life Sciences

All rights reserved.